Limor Helpman

Juravinski Cancer Centre

Papers

4

Total Citations

32

H-Index

3

About

Dr. Limor Helpman is a leading gynecologic oncologist whose research focuses on optimizing surgical outcomes for early-stage cervical cancer. As a key member of the Canadian Cervical Cancer Collaborative (4C), she has driven critical investigations into how surgical approach—abdominal, minimally invasive, or vaginal—affects patient prognosis. Her landmark 2022 study, with 15 citations, compared hysterectomy techniques for stage IA1/IA2 cervical cancer, providing evidence that minimally invasive surgery may carry higher risks for macroscopic disease. Dr. Helpman’s subsequent work (7 citations each) demonstrated that preoperative conization can mitigate these risks and that surgical margin status varies by approach, directly influencing recurrence. Her most recent 2024 study (3 citations) further explores the safety of vaginal surgery, expanding options for tailored care. Collectively, her research has reshaped clinical decision-making, emphasizing that no residual disease on hysterectomy specimens does not guarantee favorable outcomes. Dr. Helpman’s contributions are vital for surgeons and patients navigating the trade-offs between oncologic safety and surgical morbidity, cementing her as a pivotal voice in cervical cancer management.

Research Focus

Key Achievements

3
H-Index
4
Papers
32
Total Citations
8
Avg Citations/Paper
🏆 Most Cited Paper
Comparison of outcomes between abdominal, minimally invasive and combined vaginal-laparoscopic hysterectomy in patients with stage IAI/IA2 cervical cancer: 4C (Canadian Cervical Cancer Collaborative) study
15 citations · 2022
📈 Most Prolific Year: 2023 (2 Papers)
🤝 Key Collaborators: 23
🏛 Institutions: Juravinski Cancer Centre

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago